


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.31%
-0.10%
+11.28%
-4.04%
+0.72%
MREO
Mereo BioPharma Group
$0.49
Strengths

Upgraded on attractively valued
Risk Analysis

Investors losing their confidence
MREO Price Performance
$2.31 (-78.79%)
$1.92 (-74.48%)
$1.77 (-72.32%)
$3.02 (-83.77%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors losing their confidence
Future
Future
![]()
MREO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MREO Street Sentiment is unimpressive and have negative views on the near-term outlook
MREO has Low risk level
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels
MREO
Mereo BioPharma Group
0.49
-6.64%
AN
AutoNation
211.85
-1.12%
UA
Under Armour
6.21
0.00%
JBLU
JetBlue Airways
5.08
-3.79%
NWBI
Northwest Bancshares
12.66
+1.36%
What is MREO current stock price?
What are MREO stock strengths?
What is MREO Risk Level?
What is MREO market cap and volume?
What is MREO current Stock IQ?
Should I buy MREO stock right now?
Is MREO a Strong Buy right now?
What does a 'Strong Buy' rating mean for MREO?
What does a 'Strong Sell' rating mean for MREO?
What factors influence MREO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.31%
-0.10%
+11.28%
-4.04%
+0.72%
MREO
Mereo BioPharma Group
Current Price
$0.49
Stock Insights
Strengths

Upgraded on attractively valued
Risk Analysis

Investors losing their confidence
Recently Viewed
MREO
Mereo BioPharma Group
0.49
-6.64%
AN
AutoNation
211.85
-1.12%
UA
Under Armour
6.21
0.00%
JBLU
JetBlue Airways
5.08
-3.79%
NWBI
Northwest Bancshares
12.66
+1.36%

MREO Price Performance
$2.31 (-78.79%)
$1.92 (-74.48%)
$1.77 (-72.32%)
$3.02 (-83.77%)
MREO Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors losing their confidence
Future
Future
![]()
MREO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MREO Street Sentiment is unimpressive and have negative views on the near-term outlook
MREO has Low risk level
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels
Overall Wall Street Rating
STRONG SELL
Dec 30, 2025
Upgrade
Hold
Jefferies
MREO Stock IQ
MREO Latest Analysis
Mereo BioPharma Group plc (MREO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow.
Wed Jan 14, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MREO Stock trends
MREO Stock performance
MREO Stock analysis
MREO investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.